Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Using brain stimulation to reduce aggression in adults with developmental disabilities

Official title: The Use of Transcranial Direct Current Stimulation (tDCS) to Reduce Impulsivity and Aggression in Adults With Developmental Disabilities: The tDCS-RIADD Randomized Controlled Trial Protocol

Run by Queen's University · NCT04732052 · Data updated 2026-11-12

This study is testing if a brain stimulation technique can help reduce impulsivity and aggression in adults with developmental disabilities.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment60 (estimated)
SponsorQueen's University
Academic / other
Locations1 site (Kingston, Ontario)
StatusRecruiting
StartedSeptember 1, 2022
Main results expectedSeptember 30, 2027
Study endsDecember 31, 2028
Registry record updatedAugust 12, 2026
Trial IDNCT04732052 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18-64 with a developmental disability and a recent history of aggression.

Probably not a fit

Patients with a history of epilepsy, brain injury, or those with certain medical implants may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of transcranial Direct Current Stimulation (tDCS) in reducing impulsivity and aggression in adults with developmental disabilities. It employs a randomized controlled trial design with 60 participants aged 18 to 65 who have a history of aggression. Participants will receive either active tDCS or a sham treatment across three sessions, with behavioral assessments conducted before, immediately after, and at one and four weeks post-treatment. The study aims to provide insights into the potential of non-invasive brain stimulation techniques for managing aggressive behaviors.

Why it matters

Potential benefit: If successful, this approach could significantly reduce aggressive behaviors in individuals with developmental disabilities, improving their quality of life and interactions with others.

How similar studies have gone: While the use of tDCS is a relatively novel approach in this context, similar studies have shown promise in modulating impulsivity and aggression in other populations.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18-64 years
* Diagnosis of a developmental disability
* History of one or more incidents of aggression in the last month
* Consent to participate in the trial by the individual or their Substitute Decision Maker

Exclusion Criteria:

* History of epilepsy or seizures
* History of acquired brain injury
* Having metal in the brain/skull, e.g. splinters, fragments or clips
* Having a cochlear implant
* Having an implanted neuro-stimulator (e.g. direct brain stimulation, epidural/subdural stimulation, vagal nerve stimulation)
* History of brain surgery of procedure
* History of severe adverse reaction to tDCS
* Having a cardiac pacemaker or intracardiac lines
* Current alcohol or drug misuse
* Having a sensitive scalp

Where it's running

  • Providence Care Hospital
    Kingston, Ontario, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Just-in-Time Coping Prompts for College Students

    We’re testing whether sending brief coping tips at moments of emotional shift can influence how college students react online, drink, or eat when feelings spike.

    Recruiting University of Florida · Gainesville, Florida · NCT07789314

  • Momentary Coping Prompts and Hair Steroids in College Students

    This trial tests whether sending brief coping prompts at moments of emotional volatility helps college students respond to emotions, while collecting hair samples to see if long-term stress hormones relate to those responses.

    Recruiting University of Florida · Gainesville, Florida · NCT07782398

  • Virtual reality program to reduce aggression in young offenders

    This program will test whether adding virtual reality to a four-session intervention helps reduce aggressive behavior in 12–18-year-old juvenile offenders more than the same intervention without VR or their usual treatment.

    Recruiting Universidad Francisco de Vitoria · Pozuelo de Alarcón, Cominity of Madrid · NCT07484919

  • Virtual reality mindfulness for reducing aggression in schizophrenia

    We will test whether a virtual reality mindfulness program can help people with schizophrenia or schizoaffective disorder reduce impulsive aggression.

    Recruiting at 2 sites Manhattan Psychiatric Center · New York, New York and 1 other locations · NCT07434479

  • Propranolol for aggression, self-injury, and severe disruptive behaviors in adolescents and adults with autism

    This trial will test whether propranolol can reduce aggression, self-injury, and other severe disruptive behaviors in people with autism aged 12 to 40.

    Recruiting at 2 sites Phase 2 New York State Psychiatric Institute · Staten Island, New York and 1 other locations · NCT07091279

  • Step-by-Step: Stepped care for children with defiant or aggressive behavior

    This project tests a stepped care program for families of 8–16-year-olds with defiant or aggressive behavior, starting with an online parenting course and adding virtual-reality–assisted CBT for the child or parent or usual clinic care if more help is needed.

    Recruiting Karolinska Institutet · Solna · NCT06902649

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.